As most tumors respond readily to dopamine agonists in terms of reductions in prolactin levels and decreased volume, radiotherapy should now rarely be used in the treatment of prolactinoma.

Pathological hyperprolactinemia can be caused by various disturbances of the neuroendocrine mechanisms governing prolactin secretion. Prolactinomas, which are tumors of pituitary lactotrophs ...

An individualized treatment regimen with high-dose cabergoline may help women with tumor-related hyperprolactinemic infertility to achieve pregnancy, say researchers from Japan. “Our findings ...